Trevi Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Trevi Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Trevi Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Trevi Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $473k | 52k | 9.15 |
| 2025-06-30 | $238k | 43k | 5.47 |
| 2025-03-31 | $237k | 38k | 6.29 |
| 2024-12-31 | $121k | 29k | 4.12 |
| 2024-09-30 | $95k | 29k | 3.34 |
| 2024-06-30 | $42k | 14k | 2.98 |
| 2024-03-31 | $62k | 18k | 3.45 |
| 2023-09-30 | $55k | 25k | 2.18 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft